- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Most Popular Stocks
U.S. Pharmaceuticals & Biotech Most Popular Stocks
Results
1177
Most Popular Stocks on the market
1,177 companies
TetraLogic Pharmaceuticals
Market Cap: US$24.0
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases.
TLOG
US$0.000001
7D
0%
1Y
n/a
Verde Science
Market Cap: US$23.0
A pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.
VRCI
US$0.000001
7D
0%
1Y
n/a
Longport
Market Cap: US$23.0
Develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States.
LPTI
US$0.000001
7D
0%
1Y
n/a
Regnum
Market Cap: US$22.0
Develops and commercializes therapeutics that treat rare and infectious diseases.
RGMP
US$0.000001
7D
0%
1Y
-100.0%
Applied Biosciences
Market Cap: US$21.0
Focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas.
APPB
US$0.000001
7D
0%
1Y
n/a
VIA Pharmaceuticals
Market Cap: US$20.0
A development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.
VIAP
US$0.000001
7D
0%
1Y
0%
Corix Bioscience
Market Cap: US$20.0
Provides cannabidiol (CBD) oil for various medicinal purposes.
CXBS
US$0.000001
7D
0%
1Y
n/a
Korver
Market Cap: US$17.0
Engages in the design and manufacture of integrated machine controls that are sold to manufacturers of plastic parts for the automotive, household products, and electronics industries worldwide.
KOVR
US$0.000001
7D
0%
1Y
n/a
IR Biosciences Holdings
Market Cap: US$17.0
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States.
IRBS
US$0.000001
7D
0%
1Y
n/a
IMV
Market Cap: US$14.0
Operates as a clinical-stage immuno-oncology company.
IMVI.F
US$0.000001
7D
0%
1Y
-90.0%
Tibet Pharmaceuticals
Market Cap: US$14.0
A specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines.
TBET
US$0.000001
7D
0%
1Y
n/a
PhaseRx
Market Cap: US$11.0
A biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy.
PZRX.Q
US$0.000001
7D
0%
1Y
n/a
BG Medicine
Market Cap: US$11.0
Engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States.
BGMD
US$0.000001
7D
0%
1Y
n/a
Proteonomix
Market Cap: US$7.0
A biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives.
PROT
US$0.000001
7D
0%
1Y
n/a
VioQuest Pharmaceuticals
Market Cap: US$6.0
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases.
VOQP
US$0.000001
7D
0%
1Y
n/a
Adynxx
Market Cap: US$5.0
A clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases.
ADYX
US$0.000001
7D
0%
1Y
n/a
Acusphere
Market Cap: US$4.0
Operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.
ACUS
US$0.000001
7D
0%
1Y
n/a
Eloxx Pharmaceuticals
Market Cap: US$3.0
A clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases.
ELOX
US$0.000001
7D
-100.0%
1Y
-100.0%
Synvista Therapeutics
Market Cap: US$2.0
A product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease.
SYNI
US$0.000001
7D
0%
1Y
0%
Biostar Pharmaceuticals
Market Cap: US$2.0
Develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China.
BSPM
US$0.000001
7D
0%
1Y
n/a
Poniard Pharmaceuticals
Market Cap: US$1.0
A biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics.
PARD
US$0.000001
7D
0%
1Y
0%
G-H-3 International
Market Cap: US$0
Develops products for addressing factors, which cause aging and deterioration in the body.
GHTI
US$0.000001
7D
0%
1Y
n/a
Cannalink
Market Cap: US$0
A development stage company that intends to develop cannabidiol based products and provide services to emerging companies in the medical marijuana and industrial healthcare sector.
CNLK
US$0.0002
7D
0%
1Y
0%
TRANSNATIONAL CANNABIS
Market Cap: US$0
Through its subsidiaries, engages in the cannabis business in Canada and internationally.
TRCN.F
US$0.000001
7D
0%
1Y
0%
Cardax
Market Cap: US$0
A biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.
CDXI
US$0.000001
7D
0%
1Y
n/a